The protein kinase DYRK2 as a new regulator of protein homeostasis

Add to your list(s) Download to your calendar using vCal

• Dr Laureano de la Vega; CRUK Fellow and Group Leader, School of Medicine, Division of Cellular Medicine, University of Dundee
• Wednesday 12 August 2020, 12:00-13:00
• Zoom Seminar.

If you have a question about this talk, please contact Bobbie Claxton.

This seminar will be online via zoom - Please ensure that you mute your microphones when joining the presentation

Cancer cells are exposed to high levels of cellular stress and they depend on stress-relief pathways in order to survive and proliferate. To survive the proteotoxic stress produced by the accumulation of excess and often misfolded proteins, cancer cells can either a) increase protein folding capacity (controlled by the transcription factor HSF1 ) or b) increase protein degradation (by the autophagy and ubiquitin proteasome system). In this talk I will show how in triple negative breast cancer (TNBC) cells, the dual-specificity tyrosine-regulated kinase 2 (DYRK2) is an upstream positive regulator of both HSF1 and the proteasome. This presents DYRK2 as a positive regulator of two main mechanisms by which aneuploid cells adapt, survive and become malignant, and thus highlights this kinase as a potential therapeutic target.

Join Us: https://zoom.us/j/97457973301?pwd=ZjBqaW4zZXhsVSsvNXJOMklvVXR6QT09

Meeting ID: 974 5797 3301 Password: 596384

This talk is part of the Babraham Seminar series.

This talk is included in these lists:

• Babraham Seminar
• Graduate-Seminars
• Zoom Seminar
• se393's list

Note that ex-directory lists are not shown.